--- title: Doris Molina-Henry to Participate In Discussion at ACNP Annual Meeting description: Dr. Doris Molina-Henry from ATRI will be participating in a discussion on the latest advancements in Alzheimer's treatment at the ACNP 2024 Annual Meeting. image: https://atrinews.usc.edu/hubfs/Screenshot%202024-11-14%20at%203.57.37%20PM.png --- [![3L_USC-EFATRI_Card-Blk_RGB](https://atrinews.usc.edu/hs-fs/hubfs/3L_USC-EFATRI_Card-Blk_RGB.png?width=2000&name=3L_USC-EFATRI_Card-Blk_RGB.png)](https://atri.usc.edu/) - About - [Mission and Vision](https://atri.usc.edu/about/#top) - [ATRI Leadership](https://atri.usc.edu/about/#leadership) - [Timeline](https://atri.usc.edu/timeline/) - [Careers](https://usccareers.usc.edu/location/san-diego-jobs/1728-1209/6252001-5332921-5391811/4) - Research - Clinical Trials - [Groups](https://atri.usc.edu/groups/) - [Studies](https://atri.usc.edu/studies/) - [Site Locations](https://atri.usc.edu/site-locations/) - [Participate](https://atri.usc.edu/take-action/) - [Basic Science](https://atri.usc.edu/ntrd/) - Education - [Student Summer Research Program](https://atri.usc.edu/student-summer-research-program/) - People - [Our People](https://atri.usc.edu/our-people/) - [Leadership & Faculty](https://atri.usc.edu/our-people/#leadership-faculty) - [Team Leads](https://atri.usc.edu/our-people/#team-leads) - [Teams](https://atri.usc.edu/our-people/#teams) - Resources - [News](https://atrinews.usc.edu) - [Events Calendar](https://atri.usc.edu/events/) - [Resource Library](https://atrinews.usc.edu/resources) [Take action](https://atri.usc.edu/take-action/) # Doris Molina-Henry to Participate In Discussion at ACNP Annual Meeting Dr. Doris Molina-Henry We're thrilled to announce Doris Molina-Henry's participation in the upcoming American College of Neuropsychopharmacology (ACNP) Annual Meeting. This year's meeting is on December 8-11, 2024 in Phoenix, Arizona. The ACNP meeting is a premier forum for researchers and clinicians to share cutting-edge knowledge on brain health and pharmacotherapeutics. Molina-Henry, a leading researcher at ATRI, will be part of a group study session titled "Will Recent Therapeutic Advances Change the Clinical Course of Alzheimer's Disease?" Scheduled for Tuesday, December 10th, the discussion will delve into the exciting treatment possibilities now available for Alzheimer's Disease and their implications. Molina-Henry will explore the biomarker eligibility differences across racial and ethnic populations. This interactive session is a must-attend for anyone interested in the latest developments in Alzheimer's research. Molina-Henry will be joined by a distinguished panel of experts, fostering a dynamic discussion and offering valuable insights into the future of Alzheimer's care. Registration for the ACNP Annual Meeting is [now open](https://acnp.societyconference.com/v2/). All researchers, clinicians, and healthcare professionals with an interest in Alzheimer's Disease should consider attending. We also encourage you to follow [Doris Molina-Henry's work](https://www.linkedin.com/in/doris-molina-henry-22320433?lipi=urn%3Ali%3Apage%3Ad_flagship3_profile_view_base_contact_details%3BQQgkgsdMQ%2Bas1%2BzRabxsvQ%3D%3D) and sign up for our newsletter below. [back to all news](https://atrinews.usc.edu) [![trimmed3_3L_USC-EFATRI_Card-Blk_RGB](https://atrinews.usc.edu/hs-fs/hubfs/trimmed3_3L_USC-EFATRI_Card-Blk_RGB.png?width=200&height=63&name=trimmed3_3L_USC-EFATRI_Card-Blk_RGB.png)](https://atri.usc.edu/)   9860 Mesa Rim Road, San Diego, CA 92121 ATRI-info@atri.usc.edu Phone: (858) 964-4644 Fax: (858) 622-1904 [Follow us on LinkedIn](https://www.linkedin.com/company/alzheimer-s-therapeutic-research-institute/) [Follow us on Twitter](https://twitter.com/ATRI_USC) [Follow us on Facebook](https://www.facebook.com/USCATRI) - [Contact](https://atri.usc.edu/contact/) - [Take Action](https://atri.usc.edu/take-action/) - [Directory](https://atri.usc.edu/our-people/) - [Digital Accessibility](https://accessibility.usc.edu/accessibility-at-usc/digital-accessibility/) ## Sign up for our Newsletter ### Stay up to date with the latest news in Alzheimer’s therapeutics.